EFTA01388661

Differentiated Approved Commercial Reimbursed Derisked Proposed raise: $20-25mm Investment proceeds will be used to: • Build a robust commercial sales and marketing infrastructure ▪ Expand geographically, specifically in the sun-belt states of Florida, Georgia, Texas, Arizona and California ▪ Hybrid distribution strategy to include direct representation and partnership with independent agents that focus upon novelty ▪ Launch, commercialize, and tightly integrate unique and low-cost navigation system for maximized pull through of implant platform • Continue to innovate highly-engineered novelty minimally-invasive products LINKSPINE Emerging player in the minimally invasive outpatient pain market, focusing on the relatively infant "Midline" Spine Surgery sector Riding industry tailwinds of aging demographics, transition to outpatient care settings, and strong focus on faster recovery and risk-reduction Strong track record with support from the LINK Group in terms of industry and technological expertise, intellectual and financial capital, commercial experience, and etc. Deutsche Bank key contacts: Seth Damergy Managing Director Global Head of Medical Technology Benjamin Bible Vice President Healthcare, Medical Technology 8 DB-SDNY-0092346 SDNY_GM_00238530 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL EFTA01388661